Dr. Ellen Thompson
MBBS, FRCPC, Chronic Pain and Anaesthesiology
Dr. Ellen Thompson is the Medical Director of Inovo Medical. She finished her medical undergrad degree in the United Kingdom in 1970. Dr. Thompson spent a total of 5 years in general practice, for the most part in Canada. She refers to the inadequacy of education about chronic pain as the primary explanation for leaving general practice.
From 1978-1981 she finished a residency training program in anesthesia in Ottawa, where she picked up experience at the McMaster-Chedoke Pain Clinic in Hamilton. Since 1982, she has split her clinical practice between operating room anaesthesiology and treating patients with chronic pain.
Her extraordinary interest and research in pain have been displayed internationally, nationally and locally. They include: the utilization of ketamine in neuropathic pain, Botox injections into head/neck trigger points, multicentre trial of oxycontin versus codeine/acetaminophen in chronic low back pain, the utilization of IV lidocaine in patients with refractory neuropathic pain, advancement of a triage/treatment place for ideal and timely treatment of sub-acute spinal pain with the objective of avoiding chronicity and interpreting basic science data on chronic pain components into better patient care.
Mathieu Bélanger, MD, CCFP, CPSO Recognized Specialist (Chronic Pain), is the founder and President of Inovo Medical. Dr. Bélanger began his academic career by earning an undergraduate degree in kinesiology (i.e., the science of body mechanics) before enrolling in medicine at the University of Montréal. He is particularly interested in pain related to sports injuries and musculo-skeletal disorders. This interest led him to travel extensively for various types of training on pain treatment given by leading experts. Since then, his objective has been to play an active role in the development and delivery of the most sophisticated and effective treatments for chronic pain. By founding Inovo Medical, Dr. Bélanger hopes to deploy stem-cell technology in Canada, given that the results achieved with this technology are revolutionizing pain medicine.